OWM
ABBV icon

Omnitrust Wealth Management’s AbbVie ABBV Stock Holding History

Omnitrust Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$387K Sell
1,780
-9
-0.5% -$2K 0.5% 28
2025
Q4 		$409K Buy
+1,789
New +$408K 0.52% 34
2025
Q2 		$402K Buy
+1,596
New +$297K 0.47% 33

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Omnitrust Wealth Management's ABBV Position: Q1 2026 in Review

Omnitrust Wealth Management reduced its AbbVie (ABBV) stake by 0.5% in Q1 2026, selling an estimated $2K and leaving 1,780 shares worth $387K. The position accounts for 0.5% of the portfolio, ranked #28.

Omnitrust Wealth Management first reported a position in ABBV in Q2 2025 and has held it in 3 quarters since. The position peaked at $409K in Q4 2025. 4,103 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Omnitrust Wealth Management held 1,780 shares of AbbVie worth $387K as of Q1 2026.
  • Omnitrust Wealth Management sold 9 AbbVie shares in Q1 2026, an estimated $2K.
  • AbbVie made up 0.5% of Omnitrust Wealth Management's portfolio in Q1 2026, its #28 holding.
  • Omnitrust Wealth Management first reported a position in AbbVie in Q2 2025 and has held it in 3 quarters since.
  • Omnitrust Wealth Management's AbbVie position peaked at $409K in Q4 2025.
  • 4,103 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Omnitrust Wealth Management's 13F filing for Q1 2026, filed 23 Apr 2026.